Oncology studies present specific challenges. These include unknowns related to the number of visits each patient will have, differing patient visit schedules, and the impact of rescue medication on study drug expiration dates.
An additional complexity relates to the sourcing of standard-of-care (SoC) treatments and how sponsors account for their supply at global investigative sites.
In this webinar, Calyx’s Peter Tarbox shares the RTSM factors oncology trial sponsors should consider in their IRT design, focusing on how advanced IRT systems can accommodate changes in centrally and locally sourced medication for optimal clinical trial supply management.
WHEN
September 13, 2023
